William Blair Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.7M Sell
29,051
-2,965
-9% -$3.01M 0.09% 210
2025
Q4
$34.4M Buy
32,016
+16,641
+108% +$15.9M 0.1% 180
2025
Q3
$11.7M Sell
15,375
-5,192
-25% -$3.86M 0.03% 313
2025
Q2
$16M Sell
20,567
-25,255
-55% -$19.6M 0.04% 305
2025
Q1
$37.8M Buy
45,822
+467
+1% +$389K 0.11% 173
2024
Q4
$35M Buy
45,355
+18,193
+67% +$15.1M 0.09% 212
2024
Q3
$24.1M Buy
27,162
+25,219
+1,298% +$22.7M 0.06% 280
2024
Q2
$1.76M Sell
1,943
-37
-2% -$29.6K ﹤0.01% 355
2024
Q1
$1.54M Buy
+1,980
New +$1.41M ﹤0.01% 345
2016
Q2
Sell
-458,539
Closed -$33M 465
2016
Q1
$33M Buy
+458,539
New +$34.7M 0.13% 161

Other funds holding LLY

William Blair Investment Management's LLY Position: Q1 2026 in Review

William Blair Investment Management reduced its Eli Lilly (LLY) stake by 9.3% in Q1 2026, selling an estimated $3.01M and leaving 29,051 shares worth $26.7M. The position accounts for 0.09% of the portfolio, ranked #210.

William Blair Investment Management first reported a position in LLY in Q1 2016 and has held it in 10 quarters since. The position peaked at $37.8M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • William Blair Investment Management held 29,051 shares of Eli Lilly worth $26.7M as of Q1 2026.
  • William Blair Investment Management sold 2,965 Eli Lilly shares in Q1 2026, an estimated $3.01M.
  • Eli Lilly made up 0.09% of William Blair Investment Management's portfolio in Q1 2026, its #210 holding.
  • William Blair Investment Management first reported a position in Eli Lilly in Q1 2016 and has held it in 10 quarters since.
  • William Blair Investment Management's Eli Lilly position peaked at $37.8M in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on William Blair Investment Management's 13F filing for Q1 2026, filed 8 May 2026.